Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Cytokinetics 8 found (18 total)

alternate case: cytokinetics

Astellas Pharma (2,460 words) [view diff] exact match in snippet view article find links to article

December 2014, Astellas expanded its 18-month-old collaboration with Cytokinetics, focusing on the R&D and commercialization of skeletal muscle activators
Aficamten (333 words) [view diff] exact match in snippet view article find links to article
Aficamten (CK-274) is a cardiac myosin inhibitor developed by Cytokinetics for the treatment of obstructive hypertrophic cardiomyopathy. Chuang, Chihyuan;
Omecamtiv mecarbil (1,539 words) [view diff] exact match in snippet view article find links to article
S2CID 9411257. Mast J (9 October 2020). "R&D Amgen's big cardiovascular bet with Cytokinetics hits PhIII primary but dramatically disappoints investors". Endpoints
Lawrence S.B. Goldstein (451 words) [view diff] exact match in snippet view article find links to article
research. As a cofounder and consultant of the biotechnology company Cytokinetics, Inc. he has also had an active role in private industry. Goldstein has
Kinesin-like protein KIF11 (7,112 words) [view diff] exact match in snippet view article find links to article
promising preclinical studies, ispinesib (SB-715992; Cytokinetics/GSK), SB-743921 from Cytokinetics/GSK, MK-0731 from Merck, filanesib (ARRY-520) (Array
Reldesemtiv (80 words) [view diff] exact match in snippet view article find links to article
sclerosis. It is a troponin activator. "Reldesemtiv - Astellas Pharma/Cytokinetics". AdisInsight. Springer Nature Switzerland AG. Collibee SE, Bergnes G
Foresite Capital (894 words) [view diff] exact match in snippet view article find links to article
Ascendis, Blueprint Medicines, CG Oncology, Color Genomics, Cue Health, Cytokinetics, DNAnexus,[citation needed] Editas Medicine, Eikon Therapeutics, Element
Spinal muscular atrophy (10,010 words) [view diff] exact match in snippet view article find links to article
Reldesemtiv (CK-2127107, CK-107) is a skeletal troponin activator developed by Cytokinetics in cooperation with Astellas. The drug aims at increasing muscle reactivity